 |  | 

Chemotherapy Used Too Often at End of Life
[05/14/2001; Reuters Health]
SAN FRANCISCO (Reuters Health) - Chemotherapy is used
in approximately one third of patients who have cancers
that are not likely to respond to the treatment during the last
6 months of their life, according to results of a new study.
The
finding ``strongly suggests overuse of chemotherapy at the end
of life,'' lead author Dr. Ezekiel J. Emanuel told attendees
here at the annual meeting of the American Society of Clinical
Oncology (news - web sites). ``Many are concerned with the quality
of end-of-life care and specifically that patients should not
be overtreated with ineffective therapies that won't improve
their quality of life,'' Emanuel told Reuters Health.
Chemotherapy
can have a number of side effects, including nausea, vomiting,
fatigue and hair loss. Emanuel, of the National Institutes of
Health (news - web sites), and his team looked at the billing
records of nearly 8,000 patients who died from cancer in the
state of Massachusetts in 1996.
``What we found is that in the
last year of life, 41% of patients received chemotherapy, 33%
had chemotherapy in the last 6 months of life and 25% received
chemotherapy in the last 3 months of life,'' he said.
|
 |  |  | 
 #311
beta-carotene,retinoic acid,
quercetin & genistein
 Altered Nutritional/Inflammatory Status:Increased Toxicity Risk Supplement w/Magnesium, Potassium: Cisplatin Dietary Enhancement of Mitomycin C Multivitamin/Vit E Helped: Breast Ca Chemo Metab Abnormalities w/weight loss & Chemo/RTx Head/Neck
|  |  |  | 
 ABC News, December 2007
as presented at the San Antonio Breast
Cancer Symposium

|  |  |  |  | 
 Patient perspective from Jean
about Fred's colon cancer experience

|  |  |  | 
 Annals of Internal Medicine, 7/01
 Older Adults Receive Intensive Chemo at End of Life
|  |  |  |  | 
 Environmental Toxicology and Pharmacology
January 2008

|  |  |  | 
 Annals of Oncology, 1/02
 Optimal Duration of CMF-Treatment Failure/Overall Survival
|  |  |  |  | 
 Source: Bionumerik Pharmaceuticals
6/04
 PK Analysis of 5-FU Predicts Life-threatening Toxicities Warfarin (Coumadin ) & Some Chemotherapies CLASH Hiccups: Adverse Reaction to Chemo Unusual Complication: Herpes Simplex... Severe Nail Changes From Docetaxel Risk Factors: Chemo-associated Venous Thromboembolism Hearing Loss: Cisplatin (Esp Every Two Weeks) Anthracyclines: Children's Arteries Damaged Serious Adverse Events GREATER Than Prior Reporting 'Side' Effects of Chemotherapeutic Agents
|  |  |  | 
 Alternative Medicine Reviews, 1999
and more articles, IMPORTANT stuff
 Introduction and Conflicting Views Antioxidant Supplementation on Chemotherapeutic Efficacy:systematic review Antioxidant Supplementations in Men Reduces Incidence CA References Use of Antioxidants & Cytotoxic Treatments Dietary Antioxidants & Chemotherapy Antioxidants Resolve Rtx Adverse Effects Review of Italian Studies on Veg/Fruit/Antioxidants Multiple Antioxidants Improve Efficacy Systemic Screening of Total Antioxidants in Dietary Plants High Oxidation/Low Antioxidant Levels... Herbs, Vitamins & Antioxidants w/Cancer Treatments:TCM Garlic (Allium sativum) & Pharmacokinetics of Docetaxel Article References Molec targets of dietary agents 4 prvntn & thrpy of cancer. High Doses of Antioxidants Do NOT decrease efficacy of Chemo
|  |  |  |  | 
 MEDSCAPE 3/02

|  |  |  | 
 Oncology Issues, 2/02
 Lower Dose Capecitabine Better in Mets BCa
|  |  |  |  | 
 Ralph Moss, Weekly CancerDecisions.com
#36 5/14/02

|  |  |  | 
 Br J Cancer, 6/02
 Discussion: Adj Therapy Postmenopausal Women Editorial:Adjno Chemo Postmeno Lymph-Node Neg
|  |  |  |  | 
 Br J Cancer, 5/02
"Cancer Chemotherapy is Limited"

|  |  |  | 
 Written and submitted
by Gregory D. Pawelski
 Letter re Ethics/Conflicts of Interest Oncology
|  |  |  |  | 
 Oncology, 12/02
 Acral Erythrodysesthesia Syndrome:Docetaxel
|  |  |  | 
 J Clin Oncol, 4/03
 Therapy-related Acute Promyelocytic Leukemia Synergistic Effects: Grape Seed Extract & Doxorubicin
|  |  |  |  | 
 12/84

|  |  |  | 
 Breast Cancer Res Treat, 7/03

|  |  |  |  | 
 ASCO Abstract #45
 Weekly Docetaxel Causes Eye Problems
|  |  |  | 
 AACR Abstract #2721, 2003
 Vit E & Paclitaxel w/Various Cancers
|  |  |  |  | 
 Eur J Cancer, 10/03

|  |  |  | 
 Abstract # 3541
ASCO, 2004

|  |  |  |  | 
 Abstract # 3017
ASCO, 2004

|  |  |  | 
 Abstract #6128
ASCO, 2004

|  |  |  |  | 
 Intl Conf on
Molecular Targets &
Cancer Therapies, 11/04
 Heated Chemotherapy w/Surgery More Effective
|  |  |  | 
 Bone Marrow Transplant, 6/06
 Patient Perspective on High-dose Chemo
|  |  |  |  | 
 New England Journal of Medicine, Oct, 2007

|  |
Remember we are NOT Doctors and have NO medical training.
This site is like an Encylopedia - there are many pages, many links on many topics.
Support our work with any size DONATION - see left side of any page - for how to donate. You can help raise awareness of CAM. |
|